Normalizing complementary DNA by quantitative reverse transcriptase- polymerase chain reaction of β2-microglobulin: Molecular monitoring of minimal residual disease in acute promyelocytic leukemia

Diagnostic Molecular Pathology

Volumn 9, Issue 2, 2000, Pages 98-109

  Degan, Massimo ^a   Mazzocco, Francesca Tassan ^a   Di Francia, Raffaele ^a   Rossi, Francesca Maria ^a   Pinto, Antonio ^a   Gattei, Valter ^a,b  

^a Department of Medical Oncology ^*  (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Competitive RT PCR; Polymerase chain reaction; Promyelocytic leukemia; Quantitative RT PCR; Reverse transcription

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA;

ACCURACY; ACUTE MYELOBLASTIC LEUKEMIA; ANALYTIC METHOD; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; BETA 2-MICROGLOBULIN; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, NEOPLASM; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM, RESIDUAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034129505     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200006000-00006     Document Type: Article

References (43)

1. Alvarez M, Paull K, Monks A, et al. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest 1995;95:2205-14.
2. Becker-Andre' M, Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989;17:9437-46.
3. Borregaard N, Lollike K, Kjeldsen L, et al. Human neutrophil granules and secretory vesicles. Eur J Haematol 1993;51:187-98.
4. Brooks EM, Sheflin LG, Spaulding SW. Secondary structure in the 3' UTR of EGF and the choice of reverse transcriptases affect the detection of message diversity by RT-PCR. Biotechniques 1995; 19:806-15.
5. Carbone A, Gloghini A, Zagonel V, et al. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 1995;86:4617-26.
6. Cross NCP. Quantitative PCR techniques and applications. Br J Haematol 1995;89:693-7.
7. Diverio D, Riccioni R, Pistilli A, et al. Improved rapid detection of the PML/RARalpha fusion gene in acute promyelocytic leukemia. Leukemia 1996;10:1214-6.
8. Drexler HG, Borkhardt A, Janssen JW. Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. Leuk Lymphoma 1995;19:359-80.
9. Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM. The biology of chronic myeloid leukemia. N Engl J Med 1999;341:164-72.
10. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999;26:112-25.
11. Gaidano G, Parsa NZ, Tassi V, et al. In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection. Leukemia 1993;7:1621-9.
12. Gattei V, Cerrato A, Celetti A, et al. Expression of the RET receptor tyrosine kinase in normal and leukemic human hematopoietic cells. Blood 1997;89:2925-37.
13. Gattei V, Degan M, De Iuliis A, Rossi FM, Aldinucci D, Pinto A. Competitive reverse transcriptase PCR: a useful alternative to Northern blotting for quantitative estimation of relative abundances of specific mRNAs in precious samples. Biochem J 1997; 325:565-7.
14. Gattei V, Degan M, Gloghini A, et al. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 1997;89:2048-59.
15. Gattei V, Degan M, Rossi FM, et al. The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is upregulated upon differentiation. Br J Haematol 1999;105:225-40.
16. Gilliland G, Perrin S, Bunn HF. Competitive PCR for quantitation of mRNA. In: Innis MA, Gelfand DH, Sninsky JJ, Whithe TJ, eds. PCR protocols: a guide to methods and applications. New York: Academic Press, 1990:60-9.
17. Gruss H-J, Da Silva N, Hu Z-B, Uphoff CC, Goodwin RG, Drexler HG. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Leukemia 1994;8:2083-94.
18. Gussow D, Rein R, Ginjaar I, et al. The human b2-microglobulin gene. Primary structure and definition of the transcript unit. J Immunol 1987;139:3132-8.
19. Hanauer A, Mandel JL. The glycerandehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of a X chromosome linked pseudogene; amazing complexity of the gene family in mouse. EMBO J 1984;3:2627-33.
20. Kang YK, Zhan Z, Regis J, et al. Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay. Blood 1995;86:1515-24, published erratum in Blood 1995;86:4710.
21. Kidd V, Lion T. Debate round-table. Appropriate controls for RT-PCR. Leukemia 1997;11:871-81.
22. Lion T. Appropriate controls for RT-PCR. Leukemia 1996;10: 1843.
23. Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 1999; 94: 12-22.
24. Mandelli F, Diverio D, Avvisati G, et al. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997;90:1014-21.
25. Manfioletti G, Gattei V, Buratti E, et al. Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells. Blood 1995;85:1237-45.
26. Masters JN, Yang JK, Cellini A, Attardi G. A human dihydrofolate reductase pseudogene and its relationship to multiple forms of specific messengers RNA. J Mol Biol 1983;167:23-6.
27. Ng S-Y, Gunning P, Eddy R, et al. Evolution of the functional human b-actin gene and its multi-psedogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 1985;5:2720-32.
28. Pinto A, Aldinucci D, Gloghini A, et al. Human eosinophils express functional CD30 ligand and stimulate proliferation of Hodgkin's disease cells. Blood 1996;88:3299-305.
29. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984;12: 1687-96.
30. Porter-Jordan K, Lippman ME. Overview of the biologic markers of breast cancer. Hematol Oncol Clin North Am 1994;8:73-100.
31. Raeymaekers L. Quantitative PCR: theoretical considerations with pratical implications. Anal Biochem 1993;214:582-5.
32. Raeymaekers L. A commentary on the pratical applications of competitive PCR. Genome Res 1995;5:91-4.
33. Raff T, van der Giet M, Endemann D, Wiederholt T, Paul M. Design and testing of b-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 1997;23:456-60.
34. Rappolee DA, Brenner CA, Schultz R, Mark D, Werb Z. Developmental expression of PDGF, TGF-alpha and TGF-beta genes in preimplantation mouse embryos. Science 1988;241:1823-5.
35. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988;241:708-12.
36. Riedy MC, Timm EA, Stewart CC. Quantitative RT-PCR for measuring gene expression. Biotechniques 1995;18:70-6.
37. Siebert PD, Larrick JW. Competitive PCR. Nature 1992;359: 557-8.
38. Souaze' F, Ntodou-Thome' A, Tran CY, Rostène W, Forgez P. Quantitative RT-PCR: limits and accuracy. Biotechniques 1996; 21:280-5.
39. Tolan DR, Niclas J, Bruce BD, Lebo RV. Evolutionary implications of the human aldolase-A, -B, -C, and -pseudogene chromosome locations. Am J Hum Genet 1987;41:907-24.
40. Uchimaru K, Taniguchi T, Yoshikawa M, et al. Detection of cyclin Dl (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 1997;89:965-74.
41. van Rhee F, Marks DI, Lin F, et al. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow. Leukemia 1995;9:329-35.
42. Watzinger F, Lion T. Multiplex PCR for quality control of template RNA/cDNA in RT-PCR assays. Leukemia 1998;12:1984-6.
43. Wells D, Bains W. Characterization of an unusual human histone H3.3 pseudogene. DNA Seq 1991;2:125-7.